Janux Therapeutics
Price & Volume
Stats
See more52W Range | $21.73-$71.71 |
Market Cap | $2B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $10M |
Revenue Growth (YoY) | 2,177.9% |
Gross Profit (12 Mos) | -$66.2M |
Diluted EPS | -$1.67 |
News
See moreYahoo Finance • 2 months ago
Truist Initiates Coverage on Janux Therapeutics (JANX) with a Buy Rating, $100 PT
Yahoo Finance • 3 months ago
Janux is a new Buy at Truist ahead of catalyst rich H2
Yahoo Finance • 3 months ago
Janux Therapeutics Receives $10M Milestone Payment from Merck for Advancing Cancer Therapy Collaboration
Yahoo Finance • 4 months ago
Janux Therapeutics stock hits 52-week low at 22.25 USD
About
CEO | Dr. David Alan Campbell Ph.D. |
Address | 10955 Vista Sorrento Parkway, San Diego, CA, United States, 92130 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 109 |
